nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Mepyramine—Diltiazem—hypertension	0.104	0.327	CrCrCtD
Brompheniramine—Tolterodine—Labetalol—hypertension	0.0966	0.303	CrCrCtD
Brompheniramine—Tripelennamine—Bepridil—hypertension	0.0498	0.156	CrCrCtD
Brompheniramine—Promazine—Diltiazem—hypertension	0.0359	0.113	CrCrCtD
Brompheniramine—Diphenhydramine—Bepridil—hypertension	0.0325	0.102	CrCrCtD
Brompheniramine—KCNH2—Terazosin—hypertension	0.0232	0.0423	CbGbCtD
Brompheniramine—KCNH2—Doxazosin—hypertension	0.0194	0.0353	CbGbCtD
Brompheniramine—CHRM4—Nicardipine—hypertension	0.0177	0.0322	CbGbCtD
Brompheniramine—CHRM5—Nicardipine—hypertension	0.0173	0.0315	CbGbCtD
Brompheniramine—KCNH2—Bepridil—hypertension	0.0167	0.0304	CbGbCtD
Brompheniramine—KCNH2—Prazosin—hypertension	0.0159	0.029	CbGbCtD
Brompheniramine—KCNH2—Carvedilol—hypertension	0.0137	0.025	CbGbCtD
Brompheniramine—CHRM3—Nicardipine—hypertension	0.011	0.0201	CbGbCtD
Brompheniramine—CYP2C8—Torasemide—hypertension	0.00978	0.0178	CbGbCtD
Brompheniramine—CHRM1—Nicardipine—hypertension	0.0096	0.0175	CbGbCtD
Brompheniramine—CYP2C8—Candesartan—hypertension	0.0091	0.0166	CbGbCtD
Brompheniramine—CHRM2—Nicardipine—hypertension	0.00885	0.0161	CbGbCtD
Brompheniramine—KCNH2—Verapamil—hypertension	0.00866	0.0158	CbGbCtD
Brompheniramine—CYP2C9—Eprosartan—hypertension	0.00837	0.0153	CbGbCtD
Brompheniramine—CYP2C19—Torasemide—hypertension	0.00821	0.015	CbGbCtD
Brompheniramine—CYP2C19—Guanfacine—hypertension	0.00763	0.0139	CbGbCtD
Brompheniramine—CYP2C19—Metoprolol—hypertension	0.00763	0.0139	CbGbCtD
Brompheniramine—CYP2B6—Amlodipine—hypertension	0.00728	0.0133	CbGbCtD
Brompheniramine—CYP2C8—Diltiazem—hypertension	0.00689	0.0126	CbGbCtD
Brompheniramine—CYP2E1—Nifedipine—hypertension	0.00688	0.0125	CbGbCtD
Brompheniramine—CYP2C9—Torasemide—hypertension	0.00682	0.0124	CbGbCtD
Brompheniramine—CYP2D6—Labetalol—hypertension	0.00682	0.0124	CbGbCtD
Brompheniramine—CYP2D6—Nebivolol—hypertension	0.00682	0.0124	CbGbCtD
Brompheniramine—CYP2B6—Nifedipine—hypertension	0.00679	0.0124	CbGbCtD
Brompheniramine—CYP2E1—Nicardipine—hypertension	0.00677	0.0124	CbGbCtD
Brompheniramine—CYP2E1—Carvedilol—hypertension	0.00677	0.0124	CbGbCtD
Brompheniramine—CYP2B6—Nicardipine—hypertension	0.00668	0.0122	CbGbCtD
Brompheniramine—CYP2C9—Candesartan—hypertension	0.00634	0.0116	CbGbCtD
Brompheniramine—CYP2C9—Guanfacine—hypertension	0.00634	0.0116	CbGbCtD
Brompheniramine—CYP2D6—Acebutolol—hypertension	0.00624	0.0114	CbGbCtD
Brompheniramine—CYP2C19—Doxazosin—hypertension	0.00599	0.0109	CbGbCtD
Brompheniramine—CYP2D6—Metoprolol—hypertension	0.0058	0.0106	CbGbCtD
Brompheniramine—CYP2D6—Pindolol—hypertension	0.0058	0.0106	CbGbCtD
Brompheniramine—CYP2C19—Diltiazem—hypertension	0.00578	0.0105	CbGbCtD
Brompheniramine—CYP3A4—Guanethidine—hypertension	0.00572	0.0104	CbGbCtD
Brompheniramine—CYP2C8—Irbesartan—hypertension	0.00562	0.0102	CbGbCtD
Brompheniramine—CYP2C8—Amlodipine—hypertension	0.00551	0.0101	CbGbCtD
Brompheniramine—CYP2C19—Telmisartan—hypertension	0.00544	0.00992	CbGbCtD
Brompheniramine—CYP2C8—Spironolactone—hypertension	0.00541	0.00987	CbGbCtD
Brompheniramine—CYP2C8—Felodipine—hypertension	0.00531	0.00969	CbGbCtD
Brompheniramine—CYP2B6—Atorvastatin—hypertension	0.00523	0.00953	CbGbCtD
Brompheniramine—CYP2D6—Betaxolol—hypertension	0.00517	0.00943	CbGbCtD
Brompheniramine—CYP2C8—Nifedipine—hypertension	0.00514	0.00937	CbGbCtD
Brompheniramine—CYP2C8—Nicardipine—hypertension	0.00506	0.00923	CbGbCtD
Brompheniramine—CYP2C9—Diltiazem—hypertension	0.00481	0.00877	CbGbCtD
Brompheniramine—CYP2D6—Doxazosin—hypertension	0.00455	0.0083	CbGbCtD
Brompheniramine—CYP2C9—Valsartan—hypertension	0.0044	0.00802	CbGbCtD
Brompheniramine—CYP2D6—Diltiazem—hypertension	0.0044	0.00802	CbGbCtD
Brompheniramine—CYP2C19—Timolol—hypertension	0.00438	0.00799	CbGbCtD
Brompheniramine—CYP3A4—Hydralazine—hypertension	0.00434	0.00791	CbGbCtD
Brompheniramine—CYP2C19—Nicardipine—hypertension	0.00424	0.00774	CbGbCtD
Brompheniramine—CYP2B6—Verapamil—hypertension	0.00422	0.0077	CbGbCtD
Brompheniramine—CYP2C8—Atorvastatin—hypertension	0.00396	0.00722	CbGbCtD
Brompheniramine—CYP2C9—Irbesartan—hypertension	0.00392	0.00715	CbGbCtD
Brompheniramine—CYP2D6—Bepridil—hypertension	0.00392	0.00715	CbGbCtD
Brompheniramine—CYP2C19—Propranolol—hypertension	0.00391	0.00712	CbGbCtD
Brompheniramine—CYP2C9—Amlodipine—hypertension	0.00384	0.00701	CbGbCtD
Brompheniramine—CYP2C9—Felodipine—hypertension	0.00371	0.00676	CbGbCtD
Brompheniramine—CYP3A4—Guanfacine—hypertension	0.00369	0.00673	CbGbCtD
Brompheniramine—CYP2C8—Losartan—hypertension	0.00362	0.0066	CbGbCtD
Brompheniramine—CYP2C9—Nifedipine—hypertension	0.00358	0.00654	CbGbCtD
Brompheniramine—CYP2D6—Irbesartan—hypertension	0.00358	0.00654	CbGbCtD
Brompheniramine—CYP2C9—Carvedilol—hypertension	0.00353	0.00644	CbGbCtD
Brompheniramine—CYP2C9—Nicardipine—hypertension	0.00353	0.00644	CbGbCtD
Brompheniramine—CYP2D6—Amlodipine—hypertension	0.00351	0.00641	CbGbCtD
Brompheniramine—CYP2D6—Felodipine—hypertension	0.00339	0.00618	CbGbCtD
Brompheniramine—CYP2D6—Timolol—hypertension	0.00333	0.00608	CbGbCtD
Brompheniramine—CYP2C19—Atorvastatin—hypertension	0.00332	0.00606	CbGbCtD
Brompheniramine—CYP3A4—Isradipine—hypertension	0.00329	0.006	CbGbCtD
Brompheniramine—CYP2D6—Nifedipine—hypertension	0.00328	0.00598	CbGbCtD
Brompheniramine—CYP2D6—Carvedilol—hypertension	0.00323	0.00589	CbGbCtD
Brompheniramine—CYP2D6—Nicardipine—hypertension	0.00323	0.00589	CbGbCtD
Brompheniramine—CYP2C8—Verapamil—hypertension	0.0032	0.00583	CbGbCtD
Brompheniramine—CYP2C19—Losartan—hypertension	0.00304	0.00554	CbGbCtD
Brompheniramine—CYP2D6—Propranolol—hypertension	0.00297	0.00542	CbGbCtD
Brompheniramine—CYP2D6—Captopril—hypertension	0.00293	0.00535	CbGbCtD
Brompheniramine—CYP3A4—Indapamide—hypertension	0.00289	0.00528	CbGbCtD
Brompheniramine—CYP3A4—Nisoldipine—hypertension	0.00289	0.00528	CbGbCtD
Brompheniramine—CYP2D6—Clonidine—hypertension	0.00283	0.00517	CbGbCtD
Brompheniramine—CYP3A4—Diltiazem—hypertension	0.0028	0.0051	CbGbCtD
Brompheniramine—CYP3A4—Eplerenone—hypertension	0.0028	0.0051	CbGbCtD
Brompheniramine—CYP2C9—Atorvastatin—hypertension	0.00276	0.00504	CbGbCtD
Brompheniramine—CYP2C19—Verapamil—hypertension	0.00268	0.00489	CbGbCtD
Brompheniramine—CYP2C9—Losartan—hypertension	0.00253	0.00461	CbGbCtD
Brompheniramine—CYP2D6—Atorvastatin—hypertension	0.00252	0.00461	CbGbCtD
Brompheniramine—CYP3A4—Enalapril—hypertension	0.00249	0.00454	CbGbCtD
Brompheniramine—CYP3A4—Irbesartan—hypertension	0.00228	0.00416	CbGbCtD
Brompheniramine—CYP3A4—Amlodipine—hypertension	0.00223	0.00408	CbGbCtD
Brompheniramine—CYP2C9—Verapamil—hypertension	0.00223	0.00407	CbGbCtD
Brompheniramine—CYP3A4—Felodipine—hypertension	0.00215	0.00393	CbGbCtD
Brompheniramine—CYP3A4—Nifedipine—hypertension	0.00208	0.0038	CbGbCtD
Brompheniramine—CYP3A4—Carvedilol—hypertension	0.00205	0.00374	CbGbCtD
Brompheniramine—CYP3A4—Nicardipine—hypertension	0.00205	0.00374	CbGbCtD
Brompheniramine—CYP2D6—Verapamil—hypertension	0.00204	0.00372	CbGbCtD
Brompheniramine—CYP3A4—Propranolol—hypertension	0.00189	0.00344	CbGbCtD
Brompheniramine—CYP3A4—Clonidine—hypertension	0.0018	0.00329	CbGbCtD
Brompheniramine—CYP3A4—Atorvastatin—hypertension	0.00161	0.00293	CbGbCtD
Brompheniramine—CYP3A4—Losartan—hypertension	0.00147	0.00268	CbGbCtD
Brompheniramine—CYP3A4—Verapamil—hypertension	0.0013	0.00236	CbGbCtD
Brompheniramine—Chloropyramine—PTK2—hypertension	0.00122	0.453	CrCbGaD
Brompheniramine—CYP2C19—urine—hypertension	0.000839	0.07	CbGeAlD
Brompheniramine—CYP2C9—urine—hypertension	0.000651	0.0543	CbGeAlD
Brompheniramine—CYP2E1—urine—hypertension	0.000617	0.0514	CbGeAlD
Brompheniramine—CYP3A4—urine—hypertension	0.000496	0.0414	CbGeAlD
Brompheniramine—CYP2D6—urine—hypertension	0.000488	0.0407	CbGeAlD
Brompheniramine—KCNH2—cardiac ventricle—hypertension	0.000312	0.0261	CbGeAlD
Brompheniramine—CHRM4—central nervous system—hypertension	0.000309	0.0257	CbGeAlD
Brompheniramine—KCNH2—myocardium—hypertension	0.000294	0.0245	CbGeAlD
Brompheniramine—Captodiame—DRD3—hypertension	0.000289	0.107	CrCbGaD
Brompheniramine—CHRM2—heart—hypertension	0.000284	0.0237	CbGeAlD
Brompheniramine—CHRM2—cardiovascular system—hypertension	0.000268	0.0223	CbGeAlD
Brompheniramine—CHRM1—cardiovascular system—hypertension	0.000244	0.0203	CbGeAlD
Brompheniramine—CHRM5—central nervous system—hypertension	0.000241	0.0201	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A2—hypertension	0.000238	0.0884	CrCbGaD
Brompheniramine—CHRM3—smooth muscle tissue—hypertension	0.000229	0.0191	CbGeAlD
Brompheniramine—CHRM3—kidney—hypertension	0.000214	0.0178	CbGeAlD
Brompheniramine—KCNH2—heart—hypertension	0.000205	0.0171	CbGeAlD
Brompheniramine—KCNH2—cardiovascular system—hypertension	0.000194	0.0161	CbGeAlD
Brompheniramine—CHRM2—endocrine gland—hypertension	0.000184	0.0153	CbGeAlD
Brompheniramine—CYP2B6—nephron tubule—hypertension	0.000177	0.0147	CbGeAlD
Brompheniramine—KCNH2—cardiac atrium—hypertension	0.000175	0.0146	CbGeAlD
Brompheniramine—CYP2B6—adrenal cortex—hypertension	0.000174	0.0145	CbGeAlD
Brompheniramine—CYP2C8—kidney—hypertension	0.000173	0.0144	CbGeAlD
Brompheniramine—CYP2B6—heart—hypertension	0.000168	0.014	CbGeAlD
Brompheniramine—CHRM1—endocrine gland—hypertension	0.000167	0.014	CbGeAlD
Brompheniramine—CYP2C9—heart—hypertension	0.000167	0.0139	CbGeAlD
Brompheniramine—CYP2E1—nephron tubule—hypertension	0.000166	0.0138	CbGeAlD
Brompheniramine—CHRM2—central nervous system—hypertension	0.000166	0.0138	CbGeAlD
Brompheniramine—KCNH2—medulla oblongata—hypertension	0.000165	0.0138	CbGeAlD
Brompheniramine—HRH1—smooth muscle tissue—hypertension	0.000163	0.0136	CbGeAlD
Brompheniramine—HRH1—decidua—hypertension	0.00016	0.0133	CbGeAlD
Brompheniramine—CYP2B6—cardiovascular system—hypertension	0.000159	0.0132	CbGeAlD
Brompheniramine—CYP2C9—cardiovascular system—hypertension	0.000157	0.0131	CbGeAlD
Brompheniramine—CYP2B6—kidney—hypertension	0.000155	0.013	CbGeAlD
Brompheniramine—KCNH2—adrenal gland—hypertension	0.000153	0.0128	CbGeAlD
Brompheniramine—Orphenadrine—SLC6A2—hypertension	0.000153	0.0567	CrCbGaD
Brompheniramine—CHRM1—central nervous system—hypertension	0.000151	0.0126	CbGeAlD
Brompheniramine—CHRM3—endocrine gland—hypertension	0.00015	0.0125	CbGeAlD
Brompheniramine—CYP2E1—cardiovascular system—hypertension	0.000149	0.0124	CbGeAlD
Brompheniramine—CYP2E1—kidney—hypertension	0.000146	0.0122	CbGeAlD
Brompheniramine—CYP2D6—brainstem—hypertension	0.000145	0.0121	CbGeAlD
Brompheniramine—CYP2E1—cortex of kidney—hypertension	0.000142	0.0118	CbGeAlD
Brompheniramine—CYP2C19—endocrine gland—hypertension	0.000139	0.0116	CbGeAlD
Brompheniramine—CHRM3—central nervous system—hypertension	0.000135	0.0112	CbGeAlD
Brompheniramine—KCNH2—endocrine gland—hypertension	0.000133	0.0111	CbGeAlD
Brompheniramine—Diphenhydramine—CYP2C18—hypertension	0.00013	0.0483	CrCbGaD
Brompheniramine—CYP2E1—medulla oblongata—hypertension	0.000127	0.0106	CbGeAlD
Brompheniramine—Chlorphenamine—CYP3A5—hypertension	0.000126	0.0468	CrCbGaD
Brompheniramine—CYP2B6—adrenal gland—hypertension	0.000126	0.0105	CbGeAlD
Brompheniramine—HRH1—adrenal gland—hypertension	0.000123	0.0102	CbGeAlD
Brompheniramine—CYP2C8—endocrine gland—hypertension	0.000121	0.0101	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A3—hypertension	0.000121	0.045	CrCbGaD
Brompheniramine—KCNH2—central nervous system—hypertension	0.00012	0.00998	CbGeAlD
Brompheniramine—CYP2E1—adrenal gland—hypertension	0.000118	0.00983	CbGeAlD
Brompheniramine—CYP3A4—kidney—hypertension	0.000117	0.00979	CbGeAlD
Brompheniramine—CYP2D6—kidney—hypertension	0.000115	0.00963	CbGeAlD
Brompheniramine—CYP2B6—endocrine gland—hypertension	0.000109	0.00909	CbGeAlD
Brompheniramine—CYP2C9—endocrine gland—hypertension	0.000108	0.009	CbGeAlD
Brompheniramine—HRH1—endocrine gland—hypertension	0.000106	0.00887	CbGeAlD
Brompheniramine—CYP2E1—endocrine gland—hypertension	0.000102	0.00853	CbGeAlD
Brompheniramine—CYP2B6—central nervous system—hypertension	9.82e-05	0.00819	CbGeAlD
Brompheniramine—Promazine—ADRA1A—hypertension	9.81e-05	0.0365	CrCbGaD
Brompheniramine—HRH1—central nervous system—hypertension	9.59e-05	0.008	CbGeAlD
Brompheniramine—CYP2E1—central nervous system—hypertension	9.21e-05	0.00768	CbGeAlD
Brompheniramine—Chlorphenamine—SLC6A4—hypertension	9.05e-05	0.0336	CrCbGaD
Brompheniramine—CYP3A4—endocrine gland—hypertension	8.23e-05	0.00686	CbGeAlD
Brompheniramine—CYP2D6—endocrine gland—hypertension	8.1e-05	0.00675	CbGeAlD
Brompheniramine—CYP3A4—central nervous system—hypertension	7.41e-05	0.00618	CbGeAlD
Brompheniramine—CYP2D6—central nervous system—hypertension	7.3e-05	0.00608	CbGeAlD
Brompheniramine—Promazine—ADRA2A—hypertension	6.95e-05	0.0258	CrCbGaD
Brompheniramine—Diphenhydramine—PTGS1—hypertension	6.34e-05	0.0236	CrCbGaD
Brompheniramine—Promazine—DRD2—hypertension	5.27e-05	0.0196	CrCbGaD
Brompheniramine—Promazine—HTR2A—hypertension	4.07e-05	0.0151	CrCbGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT2—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADCY5—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT2—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX1—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SRC—hypertension	1.45e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1A1—hypertension	1.45e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PRKCA—hypertension	1.45e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—hypertension	1.44e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—hypertension	1.44e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARA—hypertension	1.44e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—hypertension	1.44e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT2—hypertension	1.43e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PRKCA—hypertension	1.43e-06	1.21e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1A1—hypertension	1.43e-06	1.21e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—hypertension	1.43e-06	1.21e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—hypertension	1.42e-06	1.21e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CD36—hypertension	1.42e-06	1.2e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—hypertension	1.41e-06	1.2e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CTGF—hypertension	1.41e-06	1.2e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CD36—hypertension	1.41e-06	1.19e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—hypertension	1.41e-06	1.19e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GOT2—hypertension	1.4e-06	1.19e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMGCR—hypertension	1.4e-06	1.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AGT—hypertension	1.39e-06	1.18e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SERPINE1—hypertension	1.39e-06	1.17e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SRC—hypertension	1.39e-06	1.17e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—hypertension	1.38e-06	1.17e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SERPINE1—hypertension	1.38e-06	1.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SERPINE1—hypertension	1.38e-06	1.17e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADRA2A—hypertension	1.37e-06	1.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CALM1—hypertension	1.37e-06	1.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—hypertension	1.36e-06	1.16e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SERPINE1—hypertension	1.36e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3R1—hypertension	1.35e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—hypertension	1.35e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAV1—hypertension	1.35e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—hypertension	1.35e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOA1—hypertension	1.35e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—hypertension	1.35e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGF2—hypertension	1.34e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGF2—hypertension	1.34e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RHOA—hypertension	1.34e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—hypertension	1.34e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGF2—hypertension	1.33e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RHOA—hypertension	1.33e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—hypertension	1.33e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RHOA—hypertension	1.33e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3R1—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3R1—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARA—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGF2—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3R1—hypertension	1.32e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RHOA—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3R1—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—POMC—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARA—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—INS—hypertension	1.31e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3R1—hypertension	1.3e-06	1.1e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—hypertension	1.3e-06	1.1e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—hypertension	1.3e-06	1.1e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—hypertension	1.29e-06	1.1e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TH—hypertension	1.28e-06	1.09e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AGT—hypertension	1.28e-06	1.08e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CALM2—hypertension	1.28e-06	1.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AGT—hypertension	1.27e-06	1.08e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—hypertension	1.27e-06	1.07e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CALM1—hypertension	1.26e-06	1.07e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—hypertension	1.25e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—hypertension	1.25e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CALM1—hypertension	1.25e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCG—hypertension	1.25e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A4—hypertension	1.25e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RELA—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAV1—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RELA—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOA1—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RELA—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—hypertension	1.24e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAV1—hypertension	1.23e-06	1.04e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOA1—hypertension	1.23e-06	1.04e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RELA—hypertension	1.23e-06	1.04e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MTOR—hypertension	1.22e-06	1.03e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MTOR—hypertension	1.22e-06	1.03e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—hypertension	1.21e-06	1.03e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MTOR—hypertension	1.21e-06	1.03e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—hypertension	1.21e-06	1.03e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GOT1—hypertension	1.21e-06	1.02e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MTOR—hypertension	1.2e-06	1.02e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—hypertension	1.2e-06	1.01e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—hypertension	1.2e-06	1.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—hypertension	1.19e-06	1.01e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—hypertension	1.17e-06	9.94e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—STK11—hypertension	1.17e-06	9.93e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—hypertension	1.17e-06	9.93e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—POMC—hypertension	1.17e-06	9.93e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—hypertension	1.17e-06	9.91e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—hypertension	1.17e-06	9.88e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—INS—hypertension	1.17e-06	9.87e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—hypertension	1.15e-06	9.78e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—hypertension	1.14e-06	9.7e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3R1—hypertension	1.14e-06	9.7e-06	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—hypertension	1.13e-06	9.6e-06	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—hypertension	1.13e-06	9.57e-06	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—hypertension	1.13e-06	9.54e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—hypertension	1.12e-06	9.45e-06	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—hypertension	1.12e-06	9.45e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—hypertension	1.11e-06	9.42e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—hypertension	1.11e-06	9.39e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—hypertension	1.1e-06	9.3e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—hypertension	1.09e-06	9.26e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—hypertension	1.09e-06	9.23e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—hypertension	1.08e-06	9.18e-06	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—hypertension	1.08e-06	9.14e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—POMC—hypertension	1.08e-06	9.13e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARGC1A—hypertension	1.07e-06	9.1e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNB3—hypertension	1.07e-06	9.1e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—INS—hypertension	1.07e-06	9.08e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMOX1—hypertension	1.07e-06	9.06e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—POMC—hypertension	1.07e-06	9.05e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—hypertension	1.07e-06	9.05e-06	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—hypertension	1.06e-06	9.02e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—INS—hypertension	1.06e-06	9e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—hypertension	1.06e-06	8.99e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—hypertension	1.06e-06	8.96e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—hypertension	1.06e-06	8.96e-06	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—hypertension	1.06e-06	8.95e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAT—hypertension	1.06e-06	8.94e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—hypertension	1.05e-06	8.94e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—hypertension	1.05e-06	8.93e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—hypertension	1.05e-06	8.93e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—hypertension	1.05e-06	8.91e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—hypertension	1.05e-06	8.9e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—hypertension	1.05e-06	8.88e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—hypertension	1.05e-06	8.87e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNAS—hypertension	1.05e-06	8.86e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—hypertension	1.04e-06	8.85e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—hypertension	1.04e-06	8.81e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—hypertension	1.04e-06	8.79e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK8—hypertension	1.03e-06	8.74e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—hypertension	1.03e-06	8.72e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK8—hypertension	1.03e-06	8.72e-06	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—hypertension	1.03e-06	8.71e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—hypertension	1.03e-06	8.69e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK8—hypertension	1.03e-06	8.69e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOB—hypertension	1.02e-06	8.68e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—hypertension	1.02e-06	8.66e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3R1—hypertension	1.02e-06	8.66e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—hypertension	1.02e-06	8.66e-06	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—hypertension	1.02e-06	8.64e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK8—hypertension	1.02e-06	8.6e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—hypertension	1.01e-06	8.58e-06	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—hypertension	1.01e-06	8.53e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—hypertension	1.01e-06	8.52e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—hypertension	1e-06	8.5e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—hypertension	1e-06	8.47e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—hypertension	9.97e-07	8.44e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—hypertension	9.9e-07	8.39e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—hypertension	9.82e-07	8.32e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—LPL—hypertension	9.78e-07	8.29e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—hypertension	9.78e-07	8.29e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—hypertension	9.75e-07	8.26e-06	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—hypertension	9.74e-07	8.25e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—hypertension	9.74e-07	8.25e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—hypertension	9.72e-07	8.24e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—hypertension	9.63e-07	8.16e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADCY5—hypertension	9.58e-07	8.11e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—hypertension	9.55e-07	8.09e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—hypertension	9.53e-07	8.07e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—hypertension	9.5e-07	8.05e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—hypertension	9.47e-07	8.02e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A1—hypertension	9.45e-07	8.01e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PRKCA—hypertension	9.45e-07	8.01e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—hypertension	9.4e-07	7.96e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3R1—hypertension	9.4e-07	7.96e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—hypertension	9.38e-07	7.94e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—hypertension	9.34e-07	7.92e-06	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—hypertension	9.33e-07	7.9e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3R1—hypertension	9.32e-07	7.89e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—hypertension	9.32e-07	7.89e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD36—hypertension	9.3e-07	7.88e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—hypertension	9.13e-07	7.74e-06	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—hypertension	8.99e-07	7.61e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—hypertension	8.81e-07	7.46e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—hypertension	8.77e-07	7.43e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—hypertension	8.75e-07	7.41e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—hypertension	8.74e-07	7.4e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—hypertension	8.72e-07	7.39e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—hypertension	8.71e-07	7.38e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—hypertension	8.71e-07	7.38e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—hypertension	8.69e-07	7.36e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARA—hypertension	8.64e-07	7.32e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—hypertension	8.63e-07	7.31e-06	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—hypertension	8.61e-07	7.29e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—hypertension	8.61e-07	7.29e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—hypertension	8.6e-07	7.28e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—hypertension	8.58e-07	7.26e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—hypertension	8.55e-07	7.24e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—hypertension	8.52e-07	7.22e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—hypertension	8.52e-07	7.22e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—hypertension	8.44e-07	7.15e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AGT—hypertension	8.37e-07	7.09e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CALM1—hypertension	8.23e-07	6.97e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—hypertension	8.2e-07	6.95e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—hypertension	8.15e-07	6.9e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAV1—hypertension	8.13e-07	6.88e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOA1—hypertension	8.11e-07	6.87e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—hypertension	7.77e-07	6.58e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—hypertension	7.5e-07	6.35e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—hypertension	7.43e-07	6.3e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—hypertension	7.22e-07	6.12e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—hypertension	7.2e-07	6.1e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—hypertension	7.18e-07	6.08e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—hypertension	7.15e-07	6.06e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—hypertension	7.15e-07	6.06e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—hypertension	7.14e-07	6.05e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—hypertension	7.09e-07	6e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—hypertension	7.08e-07	6e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POMC—hypertension	7.05e-07	5.97e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—INS—hypertension	7.01e-07	5.94e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—hypertension	6.59e-07	5.58e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—hypertension	6.57e-07	5.57e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—hypertension	6.55e-07	5.55e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—hypertension	6.48e-07	5.49e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—hypertension	6.42e-07	5.44e-06	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—hypertension	6.22e-07	5.27e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3R1—hypertension	6.14e-07	5.21e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—hypertension	6.14e-07	5.21e-06	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—hypertension	6.09e-07	5.16e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—hypertension	6.08e-07	5.15e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—hypertension	6.06e-07	5.13e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—hypertension	6.04e-07	5.12e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—hypertension	5.98e-07	5.07e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—hypertension	5.62e-07	4.76e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—hypertension	5.26e-07	4.46e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—hypertension	4.9e-07	4.15e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—hypertension	4.7e-07	3.98e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—hypertension	4.67e-07	3.96e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—hypertension	4.32e-07	3.66e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—hypertension	4.28e-07	3.63e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—hypertension	2.82e-07	2.39e-06	CbGpPWpGaD
